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There is great interest in the role epigenetic variation induced by non-genetic
exposures may play in the context of health and disease. In particular, DNA
methylation has previously been shown to be highly dynamic during the
earliest stages of development and is influenced by in utero exposures
such as maternal smoking and medication. In this study we sought to ident-
ify the specific DNA methylation differences in blood associated with
prenatal and birth factors, including birth weight, gestational age and
maternal smoking. We quantified neonatal methylomic variation in 1263
infants using DNA isolated from a unique collection of archived blood
spots taken shortly after birth (mean ¼ 6.08 days; s.d. ¼ 3.24 days). An epi-
genome-wide association study (EWAS) of gestational age and birth weight
identified 4299 and 18 differentially methylated positions (DMPs) respect-
ively, at an experiment-wide significance threshold of p, 1  1027. Our
EWAS of maternal smoking during pregnancy identified 110 DMPs in neo-
natal blood, replicating previously reported genomic loci, including AHRR.
Finally, we tested the hypothesis that DNA methylation mediates the
relationship between maternal smoking and lower birth weight, finding
evidence that methylomic variation at three DMPs may link exposure to
outcome. These findings complement an expanding literature on the
epigenomic consequences of prenatal exposures and obstetric factors,
royalsociety
2confirming a link between the maternal environment and
gene regulation in neonates.
This article is part of the theme issue ‘Developing
differences: early-life effects and evolutionary medicine’.publishing.org/journal/rstb
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Epigenetic mechanisms developmentally regulate gene
expression via modifications to DNA, histone proteins and
chromatin. Because epigenetic processes can be influenced by
exposure to a range of external environmental factors [1–4]
and also by genetic variation [5,6], there is great interest in
the role that epigenetic variation may play in the context of
health and disease [7]. As epigenetic marks are inherited mito-
tically in somatic cell lineages, they provide a mechanism by
which disruption early in life can be propagated through
development, producing long-term phenotypic variation.
DNA methylation is the best-characterized epigenetic modifi-
cation, stably influencing gene expression via the disruption
of transcription factor binding and recruitment of methyl-
binding proteins that initiate chromatin compaction and gene
silencing. Despite being often regarded as amechanismof tran-
scriptional repression, DNA methylation is associated with
both increased and decreased gene expression [8], and also
influences other genomic functions, including alternative
splicing and promoter usage [9].
The availability of high-throughput profiling methods for
quantifying DNA methylation across the genome at single
base resolution in large numbers of samples has enabled
researchers to perform epigenome-wide association studies
(EWAS) aimed at identifying methylomic variation associated
with environmental exposures and disease [7]. Although these
studies are inherently more complex to design and interpret
than genetic association studies [10–12], recent analyses
have documented differences in DNAmethylation in neonates
and children following exposure to a wide range of envi-
ronmental factors during gestation, including maternal
smoking, maternal diet and pollution [2,3,13]. There is also
interest in the role that DNA methylation may play as
mediator through which environmental exposures can
influence long-term health outcomes. For example, there is
evidence that the causal relationship between maternal smok-
ing during pregnancy and low birth weight is mediated
through differences in DNA methylation at specific loci
across the genome [14,15]. While noteworthy, these analyses
have been based on moderate samples sizes, have generally
not replicated the same loci, and may have overestimated
mediation effects because of invalid assumptions and
misclassification of the exposure [16].
Another active area of research concerns the utility of DNA
methylation as a biomarker for clinical monitoring and screen-
ing. The potential of a DNA methylation based predictor has
been most robustly demonstrated for age, with a number
of algorithms available, referred to as ‘epigenetic clocks’
[17–19]. There is particular interest in how measures of age
derived from DNA methylation data correlate with actual
chronological age, and also whether ‘accelerated’ epigenetic
age predicts ageing phenotypes such as mortality, cancer and
dementia [18,20,21]. There is also interest in whether other
exposures (or phenotypes) can be inferred from an epigenetic
profile. The development of an epigenetic biomarker usingneonatal blood samples might enable the evaluation of
in utero exposures, which are hard to measure objectively,
and could be a useful prospective predictor for future health
outcomes. To this end, a biomarker of maternal smoking
during pregnancy was recently developed using cord blood
samples that demonstrates high specificity (97%)—but only
moderate sensitivity (58%) [22]—demonstrating the potential
application of such approaches. Because DNA methylation is
known to be highly dynamic during the earliest stages of devel-
opment [23,24], insults during this periodmay have important
functional consequences or impact upon disease susceptibility
later in life. Of note, several psychiatric disorders are hy-
pothesized to have important neurodevelopmental origins
[25–27] and have been associated with a number of prenatal
andperinatal risk factors. For example, epidemiological studies
have reported a higher risk of autism in those born with a
low birth weight [28,29] or born pre-term [30]. Although
DNA methylation predictors for age [18] and smoking [31]
developed in childhood or adult samples have been shown
to work reasonably well, methods developed specifically
in either cord blood or neonatal samples have superior
performance at these ages [19].
In this study, we first sought to identify specific patterns
of DNA methylation in neonatal blood samples associated
with three obstetric and neonatal influences measured in
the same individuals: birth weight, gestational age and
exposure to maternal smoking. We subsequently used our
results to explore whether variable DNA methylation med-
iates the relationship between maternal smoking and low
birth weight. We attempted to address this issue by quantify-
ing methylomic variation in 1263 infants using DNA isolated
from archived blood spots taken shortly after birth (mean ¼
6.08 days; s.d. ¼ 3.24 days) originally profiled in a case–
control study of autism [32]. Although we cannot exclude
the role of DNA methylation changes occurring during
the first few days after birth, our study extends previous
research into the early-life epigenome that has used samples
collected either later in childhood or from cord blood
[13,24,33], which has the limitation that it may be contami-
nated by maternal blood [34,35]. Our findings complement
the expanding literature on the epigenomic consequences of
prenatal exposures and obstetric factors, confirming a link
between the maternal environment and markers of gene
regulation in neonates.2. Methods
(a) Overview of the MINERvA cohort
A description of the MINERvA cohort was recently published
alongside extensive details of the profiling of DNA methylation
and data quality control steps [32]. Briefly, MINERvA contains
a subset of 1316 samples from the iPSYCH autism spectrum
disorder case–control sample [36]. All perinatal data used for
case–control sample matching, plus additional information on
birth weight and maternal smoking were obtained from the
Danish Medical Birth Register or the Central Person Register.
An overview of the demographic characteristics of the MINERvA
cohort is given in electronic supplementary material, table S1. Of
note, cases and controls were matched as closely as possible.
Although rates of maternal smoking were higher in autism
cases, there was no significant difference in birth weight between
autism cases and controls.
royalsocietypublishing.org/journal/rstb
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3(b) DNA methylation profiling in MINERvA
Neonatal dried blood spot samples collected on standard Guthrie
cards and stored within the Danish Neonatal Screening Biobank
[37] were retrieved as part of the iPSYCH study [36]. Neonatal
DNA extractions and DNA methylation quantification were per-
formed at the Statens Serum Institut (SSI, Copenhagen, Capital
Region, Denmark). Briefly, DNAwas convertedwith sodium bisul-
fite using the EZ-96 DNA Methylation Kit (Zymo Research, CA,
USA) and DNA methylation was quantified across the genome
using the Infinium HumanMethylation450K array (‘450K array’)
(Illumina, CA, USA). After a stringent quality control process (out-
lined in [32]), 1263 samples (96.0%) were included for subsequent
analysis. Normalization of the DNA methylation data was per-
formed used the dasen() function in the wateRmelon package [38].
For each sample, we derived nine additional variables from the
DNAmethylation data using established algorithms: DNAmethyl-
ation age [18], gestational age [19], smoking [31] and six blood cell
composition variables [39,40]. Our previous publication on these
data demonstrated that the smoking score, despite being trained
in adults who smoked, correlated with reported maternal smoking
status from the registry data [32]. All quality control and statistical
analyses were performed using the R statistical environment
v. 3.2.1 [41].
(c) Epigenome-wide association analyses (EWAS)
We performed an EWAS of three obstetric/neonatal factors that
were robustly measured in our cohort. First, to identify DNA
methylation sites associated with birth weight (measured in
grams (g)) and gestational age (measured in weeks), a linear
model was fitted for each DNA methylation site with DNA
methylation as the dependent variable, both birth weight and
gestational age as independent variables, and a set of possible con-
founders as covariates: sex, experimental array number (i.e. chip),
days to sampling, maternal smoking (using the continuous vari-
able estimated from the DNA methylation data) and six derived
cell composition variables. Given the strong concordance between
the findings of ourmaternal smoking EWAS and those of previous
EWAS analyses of smoking (see Results), we used the derived
maternal smoking score tomake up formissing data in the registry
data and maximize power for analyses. To compare results
between autism spectrum disorder (ASD) cases and controls, we
tested for a heterogeneous effect by including an interaction term
between (i) birth weight and case–control status, and (ii) gesta-
tional age and case–control status. In these interaction models,
ASD case–control status was also included as a main effect.
Second, to identify differentially methylated positions (DMPs)
associated with registry-reported maternal smoking exposure, a
linear model was fitted for each DNA methylation site with
DNA methylation as the dependent variable, and a binary indi-
cator variable for in utero exposure to smoking in addition to a
set of possible confounders as covariates: sex, birth weight,
gestational age, experimental array number (i.e. chip), and six
derived blood cell composition variables. Significant DMPs were
identified at an experiment-wide multiple testing adjusted
threshold of p, 1  1027. Clustering of significant DMPs into
loci was performed by taking each significant site in turn, starting
with the one with the smallest p value (referred to as the index
association), identifying all other significant sites within 5 kb
upstream and downstream and merging these into a single
locus. Any less significant (i.e. larger p value) DMPs merged
with an index site were then excluded from consideration as an
index association. This procedurewas repeated until all significant
DMPs were either merged with a more significant association or
considered as an index site. Conditional analyses were performed
within lociwith at least twoDMPs by repeating the original associ-
ation analysis for the secondary signal (i.e. the less significant site),
including the most significant DNAmethylation site in that loci as
an additional covariate.(d) Replication dataset
TheAccessibleResource for IntegratedEpigenomic Studies (ARIES;
http://www.ariesepigenomics.org.uk) cohort consists of a sub-
sample of 1018 ALSPAC (http://www.bristol.ac.uk/alspac/)
child–mother pairs with Illumina 450K array DNA methylation
data generated from cord blood (n ¼ 914), and whole blood at
two time points during childhood (age 7 (n ¼ 973) and age 15 or
17 years (n ¼ 974)). The results used in this manuscript are taken
from the gestational age and birth weight EWAS performed by
Simpkin et al. [24] and presented in electronic supplementary
material, tables S1 and S3 published alongside this manuscript.(e) Mediation analyses
Mediation analyses were performed using the criteria outlined
by Baron & Kenny [42] and the Sobel test [43]. We considered
DMPs associated with registry-reported maternal smoking with-
out controlling for birth weight in our dataset (n ¼ 143 DMPs)
and tested whether the following criteria were met for each site:
(i) smoking significantly correlated with DNA methylation
level ( p , 1  1027; sex, gestational age, batch and cell
composition included as covariates);
(ii) smoking significantly correlated with birth weight with-
out adjusting the model for DNA methylation (sex and
gestational age included as covariates);
(iii) DNA methylation significantly correlated with birth
weight ( p, 1  1027; sex, gestational age, batch and
cell composition included as covariates);
(iv) the association between smoking and birth weight
decreased upon addition of DNA methylation to the
model (i.e. p value got larger; sex, gestational age, batch
and cell composition included as covariates);
(v) the Sobel test gave p, 3.50 1024 (corrected for 143 DMPs
considered, implemented through the R bda package
(https://cran.r-project.org/web/packages/bda/index.html).
DMPsmeeting the criteria for mediation were taken forward for
a sensitivity analysis that accounted for misclassification of the
exposure following the method outlined in Valeri et al. [16] using
the SIMEX procedure [44]. Our naive outcome regression model
between birth weight and registry-reported maternal smoking
exposure and naive mediator regression model between DNA
methylation and birth weight included covariates for gestational
age, sex, cellular composition and experimental chip. The naive
direct effect is then the coefficient from the outcome regression
model for maternal smoking and the naive indirect effect is the
naivedirect effectmultipliedby the estimated coefficient formaternal
smoking from themediator regression. Applying SIMEX to outcome
and mediator regressions, we obtained corrected estimates of the
regression parameters which were then used to calculate the direct
and indirect effects. We set the parameter for specificity to 1.0 as
we assume that all smokers are likely to have reported correctly,
whereas we assume that some non-smokers will have reported
incorrectly and therefore the sensitivity parameter was set to 0.6.
A bootstrap method was used to estimate the standard errors of
the estimated effects and their 95% confidence intervals (CIs).3. Results
(a) Blood cell proportions derived from DNA
methylation data correlate with birth weight and
gestational age in neonatal blood
Our first analyses aimed to explore whether measures
derived from DNA methylation data at birth (i.e. gestational
royalsocietypublishing.org/journal/rstb
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4age and blood cell composition estimates) are associated with
birth weight. We previously demonstrated the robustness
of DNA methylation data derived from neonatal blood
spots by implementing two DNA methylation clock algor-
ithms to derive estimates for (i) age in years [18] and
(ii) gestational age in weeks [19] for each sample. As
expected, we observed a strong positive correlation bet-
ween estimated and actual gestational age (r ¼ 0.602, 95%
CI ¼ (0.566, 0.636), p ¼ 3.80  102125) and a weaker posi-
tive correlation between estimated chronological age and
actual gestational age (r ¼ 0.139, 95% CI ¼ (0.0849, 0.193),
p ¼ 6.52  1027) [32]. We next extended these analyses
to investigate how birth weight correlates with these pre-
dicted ages and whether variable birth weight explains
the difference between predicted age (derived from DNA
methylation data) and actual age. Birth weight was
significantly correlated with predicted measures of both age
(r ¼ 0.119, 95% CI¼ (0.0638, 0.173), p ¼ 2.40 1025; electron-
ic supplementary material, figure S1A) and gestational age
(r ¼ 0.333, 95% CI¼ (0.0849, 0.193), p ¼ 5.15 10234; elec-
tronic supplementary material, figure S1B). However, the age
acceleration residuals—which are adjusted for reported gesta-
tional age—are not significantly associated with birth weight
(p. 0.05, electronic supplementary material, figure S1C,D),
indicating that variation in birth weight does not explain the
difference between reported gestational age and predicted
age and that other pregnancy and/or obstetric factors may
be influencing derived age estimates. Given the difficulties in
collecting large volumes of blood from neonates, little is
known about blood cell-type variation at this stage of life.
We therefore explored how predicted cellular composition
variables derived from the DNA methylation data
(see Methods) correlate with birth weight and reported
gestational age. Gestational age was positively correlated
with the estimated proportions of CD8 T-cells (r ¼ 0.140;
95% CI¼ (0.0857, 0.194), p ¼ 5.63  1027) and natural killer
cells (r ¼ 0.0722, 95% CI ¼ (0.0171, 0.127), p ¼ 0.0103), and
negatively correlated with the estimated proportion of B-cells
(r ¼ 20.231, 95% CI ¼ (20.282, 20.178), p ¼ 1.06 10216)
(electronic supplementary material, figure S2). Birth weight
was significantly negatively correlated with the estimated
proportion of monocytes (r ¼ 20.0604, 95% CI¼ (20.115,
20.00529), p ¼ 0.0317) and positively correlated with
the estimated proportion of granulocytes (r ¼ 0.0624, 95%
CI¼ (0.00727, 0.117), p ¼ 0.0266) (electronic supplementary
material, figure S3). Given the potential confounding
influence of cellular heterogeneity in EWAS analyses using
blood, these derived variables were included in all
subsequent analyses.
(b) Birth weight and gestational age are associated
with variable DNA methylation in neonatal blood
To identify DNA methylation sites associated with reported
gestational age and birth weight we next performed an
EWAS across all Illumina 450K array sites on the autosomes
and X-chromosome (n ¼ 430 676 sites), undertaking the
analyses simultaneously to minimize confounding resulting
from the strong correlation between these two obstetric
variables (r ¼ 0.491, 95% CI ¼ (0.448, 0.532), p ¼ 1.14 
10277; electronic supplementary material, figure S4). In
total, we identified 18 differentially methylated positions
(DMPs) associated with birth weight (figure 1; electronicsupplementary material, figures S5 and S6) and 4299
DMPs associated with gestational age (figure 1; electro-
nic supplementary material, figures S7 and S8) at an
experiment-wide significance threshold (p, 1  1027) (elec-
tronic supplementary material, tables S2 and S3). The
associated DMPs were characterized by a median shift in
DNA methylation of 1.40% (s.d. ¼ 0.368%) per kg and
0.406% (s.d. ¼ 0.275) per gestational week. Seven sites were
significantly associated with both birth weight and gesta-
tional age (table 1). Sensitivity analyses repeating the EWAS
excluding samples from ‘outlier’ individuals born (i) before
35 weeks (N ¼ 23) or (ii) before 32 weeks (N ¼ 5) revealed
high concordance with our primary analysis (electronic sup-
plementary material, figure S9), suggesting that the results
are robust to the presence of premature individuals.
Although the majority of DMPs associated with increased
birth weight were associated with reduced DNA methylation
(66.7%) there was not a significant bias (sign test p ¼ 0.238)
due to the small total number of DMPs identified. In contrast,
there was a highly-significant bias towards increased
DNA methylation at sites associated with older gestational
age (73.2%, sign test p ¼ 2.29  102135). Although this contra-
dicts results from a previous study using cord blood derived
DNA from the ARIES cohort (n ¼ 914), which identified
a smaller number of DMPs that were enriched for sites
showing a decrease in DNA methylation with older gesta-
tional age [24], our most significant DMPs are characterized
by reduced DNA methylation with age (electronic sup-
plementary material, table S3) and associations at sites
showing this pattern of change are significantly stronger
(Mann–Whitney p ¼ 2.58  102228). Furthermore, we find a
significant excess of consistent effects between studies indi-
cating that age-associated changes are similar in cord and
neonatal whole blood (electronic supplementary material,
figure S10). Of 148 DMPs associated with gestational age in
the ARIES cohort, 146 (98.6%) had the same direction
of effect (sign test p ¼ 6.18  10241), with 110 being signifi-
cantly associated ( p, 1  1027) in both cohorts. We found
similar consistency for our EWAS of birth weight; all 21
DMPs associated with birth weight in the ARIES cohort
had the same direction of effect in our data (sign test p,
2  102323), with two DMPs being significantly associated
( p, 1  1027) in both cohorts (electronic supplementary
material, figure S10). While the 18 DMPs associated with
birth weight are annotated to distinct genomic loci, the
4299 DMPs associated with gestational age are clustered
into 3550 distinct locations with up to 25 additional DMPs
located within 5 kb of the index DMP characterized by the
most significant association. Conditional analyses within
each genomic locus containing at least two DMPs (n ¼ 483;
13.6%) revealed evidence for independent secondary signals
for 240 DMPs in 193 of these loci (conditional p, 5 
1025), while 100 DMPs within 66 loci were only associated
as a result of their correlation with the most significant
DMP in the same loci (conditional p. 0.05; electronic supple-
mentary material, table S4). Finally, given the association
between both low birth weight and pre-term birth and
autism we tested whether the DNA methylation differences
we identified were consistent between individuals who
later went on to develop a childhood diagnosis of autism
(n ¼ 629) and matched controls (n ¼ 634). There were no sig-
nificant differences between autism cases and controls for
DMPs associated with birth weight (min. p ¼ 0.0446) or for
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Figure 1. Methylomic variation associated with birth weight and gestational age in neonates. Manhattan plots of p-values from an epigenome-wide association
study (EWAS) of (a) birth weight (g) and (b) gestational age (weeks). The red (dashed) horizontal line indicates experiment-wide significance ( p, 1  1027); the
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Table 1. DNA methylation in neonatal blood is associated with birth weight and gestational age. In total, seven differentially methylated positions (DMPs) were
associated with both birth weight and gestational age at an experiment-wide threshold of p, 1  1027. Genomic locations are based on hg19.
probe ID
EWAS of birth weight (g) EWAS of gestational age (weeks)
chr position
gene annotation
p-value
regression
coefficient p-value
regression
coefficient
UCSC
gene
name
UCSC
genic
region
cg04411893 9.881028 28.411026 2.2810212 20.003758699 chr3 185 300 709
cg05937055 4.661029 21.201025 5.2010210 20.004302303 chr1 181 128 764
cg06870470 2.971029 21.681025 6.9310228 20.01068899 chr19 11 315 767 DOCK6 body
cg13066703 2.501028 21.111025 3.6810236 20.008742825 chr1 211 526 705 TRAF5 body
cg19744173 1.8710210 21.411025 8.4110220 20.006889143 chr2 112 913 178 FBLN7 body
cg20068209 5.191028 21.371025 2.0010241 20.011959147 chr6 75 988 568 TMEM30A body
cg20076442 1.1810210 21.961025 3.2310225 20.010843225 chr8 72 745 197
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5DMPs associated with gestation age (min. p ¼ 3.51  1025)
after correcting for the number of DMPs significant in
each analysis (birth weight: p, 0.00278 corrected for18 DMPs; gestational age: p, 1.16  1025 corrected for
4299 DMPs) (electronic supplementary material, tables S2
and S3).
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6(c) Maternal smoking influences DNA methylation in
neonates at multiple loci
Exposure to tobacco smoke is known to be associated with
widespread alterations in DNA methylation in whole blood
[1], and previous analyses have demonstrated that these effects
can be detected in cord blood from neonates exposed to prena-
tal smoking [13]. One limitation of using cord blood is that
DNA methylation estimates can be influenced by contami-
nation with maternal blood, and we therefore sought to test
these whether these associations were detectable in neonatal
whole blood samples. Mothers were asked about their smok-
ing status at their first prenatal visit, early in the second
trimester of pregnancy. Among the mothers of neonates in
our cohort, 294 (25.1%) reported smoking during pregnancy
and 879 (74.9%) reported not smoking during pregnancy; we
excluded 36 mothers who reported giving up smoking at
some time during the pregnancy and 54 mothers for whom
smoking data were not available. First, we assessed whether
maternal smoking influenced derived measures of age gener-
ated from DNA methylation data in these samples. Neither
age, gestational age nor age acceleration was associated with
in utero exposure to smoking (electronic supplementary
material, figure S11).Next,we performed an EWASofmaternal
smoking exposure (n ¼ 1173, controlling for sex, birth weight,
gestational age, experimental batch, and derived cell compo-
sition variables), identifying 110 neonatal blood DMPs
associatedwithmaternal smoking (p, 1  1027) representing
70 discrete genomic loci (figure 2; electronic supplementary
material, figure S12 and table S5). Conditional analyses
within each genomic locus with at least two DMPs (n ¼ 13)
identified seven loci where a single DMP was associated with
maternal smoking (conditional p for other sites greater than0.05) and four loci characterized by secondary semi-indepen-
dent effects (conditional p for other sites less than 5  1025;
electronic supplementary material, table S6). There was no sig-
nificant bias towards a particular direction of effect (50.9%
hypomethylated; 49.1% hypermethylated, sign test p ¼ 0.924)
and the median effect was a difference of 2.28% DNAmethyl-
ation (s.d. ¼ 2.19%) (electronic supplementary material,
figure S13). There was considerable overlap with DMPs
reported in a large EWAS of maternal smoking performed in
cord blood [13] (n ¼ 6685; electronic supplementary material,
figure S14). Of note, 4847 (84.0%) of the 5768 DMPs reported
in that study were characterized by the same direction of
effect (sign test p, 2  102323) in our analysis of neonatal
blood, with 102 meeting criteria for experiment-wide signifi-
cance ( p, 1  1027) in both studies. This included
previously reported DMPs associated with tobacco smoking
in adults [1,31], such as AHRR, where five additional DMPs
were clustered with the lead signal at cg05575921, none of
which remained significant in the conditional analysis, GFI1,
which had nine DMPs including multiple independent associ-
ations, and MYO1G, which had four DMPs with evidence of
multiple independent associations (electronic supplementary
material, table S6). These findings confirm that smoking behav-
iour bymothers during pregnancy has a profound influence on
DNAmethylation in their offspring at birth and in the first few
days of life.(d) DNA methylation mediates the relationship
between maternal smoking and low birth weight
Having established that the DNA methylation signatures
associated with prenatal smoking exposure are robustly
ee
n
bi
rth
we
ig
ht
an
d
m
at
er
na
ls
m
ok
in
g.
rn
al
EW
AS
of
m
at
er
na
ls
m
ok
in
g
EW
AS
of
bi
rt
h
w
ei
gh
t
EW
AS
of
bi
rt
h
w
ei
gh
t
ad
ju
st
ed
fo
r
m
at
er
na
ls
m
ok
in
g
So
be
lt
es
t
p-
va
lu
e
re
ss
io
n
ffi
cie
nt
p-
va
lu
e
re
gr
es
sio
n
co
ef
fic
ie
nt
p-
va
lu
e
re
gr
es
sio
n
co
ef
fic
ie
nt
p-
va
lu
e
re
gr
es
sio
n
co
ef
fic
ie
nt
82
.4
18
1.
39

10
2
55
2
0.
12
08
2.
58

10
2
8
4.
18

10
2
5
2.
72

10
2
8
2
22
9.
55
6
3.
58

10
2
9
82
.4
18
8.
29

10
2
11
9
2
0.
08
19
6
1.
17

10
2
10
2.
37

10
2
5
1.
51

10
2
4
2
17
8.
77
2
8.
52

10
2
14
82
.4
18
7.
42

10
2
13
2
0.
03
98
1
3.
84

10
2
8
2.
89

10
2
5
2.
41

10
2
10
2
23
8.
06
8
1.
12

10
2
6 royalsocietypublishing.org/journal/rstb
Phil.Trans.R.Soc.B
374:20180120
7detectable in neonatal blood, and that variable DNA methyl-
ation is associated with an established outcome of maternal
smoking [45,46] we next asked whether methylomic variation
might mediate the relationship between maternal smoking in
pregnancyand lowerbirthweight. Previous attempts to explore
this using data from cord blood have been relatively inconsist-
ent [14,15], supporting a mediation role for DNA methylation
at non-overlapping DNA methylation sites. We repeated our
EWASofmaternal smoking, excluding birthweight as a covari-
ate, and identified an extended set of 143 DMPs (electronic
supplementary material, table S7) which contained 105
(95.5%) of the 110 DMPswe identified in the analysis adjusting
forbirthweight.Mediation analyses, performedusing theSobel
test (seeMethods), showed thatDNAmethylation at three sites,
annotated to three different genomic loci, met the five criteria
set out by Baron & Kenny [42] (see Methods) as providing evi-
dence formediating the association between smoking andbirth
weight (electronic supplementarymaterial, figure S15and table
S7). This included one site (cg09935388) annotated toGFI1 that
hasbeen reportedpreviously [15] and twonovelmediationsites
(cg05575921 annotated toAHRR, and cg26889659 annotated to
EXOC2) (table 2). Because smoking behaviour is prone to mis-
classification—not only owing to smokers claiming to be non-
smokers, especially during pregnancy [47], but also because a
complex behaviour is simplified into a dichotomous vari-
able—we repeated the analysis for the three significant DNA
methylation sites estimating the natural direct effect between
maternal smoking and low birth weight (i.e. not via DNA
methylation) and the natural indirect effect (i.e. via DNA
methylation) using the SIMEX (simulation and extrapolation)
procedure which incorporates misclassification [44]. Strin-
gently accounting for misclassification suggests that the
estimated mediation effect via DNA methylation identified
using the Sobel test is potentially overestimated; although the
results robustly support a significant mediation effect for
DNA methylation at cg26889659, under scenarios of more
extrememisclassification (seeMethods) the effects ofmediation
via DNA methylation at cg05575921 and cg09935388 are no
longer significantly different from 0 (electronic supplementary
material, table S8).Ta
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24. Discussion
In this study we quantified neonatal variation in DNAmethyl-
ation in 1263 infants using samples isolated from archived
blood spots taken shortly after birth. Our study finds that gesta-
tional age, birthweight andmaternal smoking are all associated
with significant DNA methylation differences in neonatal
blood, with gestational age having the most effects widespread
across the genome. These data add to a growing literature
demonstrating that prenatal and obstetric exposures can
influence epigenetic variation in early life [3,13,24,48–50], pro-
viding a potential mechanism linking them to altered gene
function and long-term health and disease outcomes.
Our use of neonatal DNA samples means that we are
uniquely positioned to identify epigenetic variation at birth,
avoiding the confounding exposures that could influence
the results from samples collected later in childhood (for
example, health and disease, nutrition, medication, and stress).
Although there have been larger studies of prenatal exposures,
a strength of our study is that we profiled whole blood from
neonatal infants rather than cord blood, minimizing the
royalsocietypublishing.org/journal/rstb
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8contamination of our samples with maternal blood DNA and
meaning our data can be more easily compared with the exten-
sive blood DNA methylation datasets derived from samples
later in life. A limitation of our sampling strategy, however, is
that no blood cell reference DNA methylation datasets specifi-
cally for use on neonatal blood are yet available, likely
reflecting the difficulties of obtaining sufficient volumes of neo-
natal blood for cell sorting and methylomic profiling. Although
there has been much written on the importance of selecting an
appropriate tissue to profile for epigenetic studies [10], the goal
of this study was to identify biomarkers of exposure, and there-
fore our use of a peripheral tissue is justified. Furthermore,
although blood spots were collected only a few days after birth
(mean ¼ 6.08days; s.d. ¼ 3.24days), it ispossible that somepost-
natal exposure topassive smokingduring the first fewdaysof life
could also have influenced our results, although the amount of
exposure in approximately 6 days is likely to be negligible.
As well as identifying specific loci at which DNA methyl-
ation is associated with early-life factors such as smoking
exposure and gestational age, we tested the hypothesis
that DNA methylation mediates established epidemiological
relationships between exposures and outcomes. We explored
the association between maternal smoking and lower birth
weight, finding evidence that methylomic variation at several
DMPs may be mechanistically involved in linking exposure
(maternal smoking) to outcome (birthweight).While our results
are consistent with previous reports, such analyses can be influ-
enced by misclassification bias [16]. Smoking, in particular, is
prone to misclassification not only owing to participants claim-
ing to be non-smokers when they are in fact smokers, a
circumstance known to be worse when reflecting smoking
during pregnancy[47], but also as a result of simplifying a com-
plex behaviour into a single dichotomous variable representing
the entire period of pregnancy. Given our robust prenatal smok-
ing exposure associations, it is plausible that themediator in our
analyses—DNA methylation—is in fact a better measure of
smoking exposure than self-reported status [16]. Of note, apply-
ing a methodology that accounts for misclassification of an
exposure reduced the magnitude of the mediation effect at all
three significant loci, suggesting that these results need vali-
dation using an alternative approach such as Mendelian
randomization [51].
While we explored whether DNA methylation lies on the
causal pathway between maternal smoking and low birth
weight, results from EWAS analyses do not distinguish
cause from effect. In fact, it is likely that the DNA methyl-
ation differences we report for birth weight and gestational
age reflect other in utero exposures or processes. For example
birth weight is known to be associated with maternal body
mass index, blood pressure and fasting glucose levels
[52–54] and the epigenetic changes we report may reflect
the downstream influences of these pathways. It is also poss-
ible that the birth-weight-associated DMPs identified in our
study reflect exposures or influences occurring in the immedi-
ate neonatal period before the blood samples were collected.
Similarly, theDNAmethylationdifferencesobserved inneonates
exposed to prenatal smoking might also be influenced by
exposure to passive smoking from the mother or father immedi-
ately after birth, although the amount of exposure in
approximately 6 days is likely to be negligible. Another potential
limitation of our design is that the analyses were performed
within the context of an autism case–control study [32]. Of
note, however, although autism cases had a higher exposure tomaternal smoking than non-autism controls, there was not sig-
nificant difference in birth weight between infants who went
on to develop autism compared with those who did not (elec-
tronic supplementary material, table S1). Finally, the nature of
the samples we profiled in this study (i.e. small amounts of neo-
natal blood) meant that additional DNA was not available for
technical validation experiments. However, the Illumina 450K
array has been shown to yield highly reproducible measures of
DNA methylation, and the observed consistency with previous
studies of maternal smoking, gestational age, and birth weight
suggests our findings are robust.5. Conclusion
Our data demonstrate that in utero exposures are associated
with detectable patterns of DNA methylation in neonatal
blood samples, highlighting the role that the prenatal environ-
ment plays in influencing gene regulation in neonates. While
previous studies have shown that maternal smoking effects
persist into later childhood [13], these have found that the
effects are attenuated, suggesting that obtaining a biomarker
as close to birth as possible will have maximal sensitivity
regarding exposures during gestation.
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